BioNexus Gene Lab (BGLC) Other Working Capital Changes (2018 - 2026)
BioNexus Gene Lab recorded quarterly Other Working Capital Changes of -$13993.0 in Q1 2026, up 76.94% quarter-over-quarter from -$60683.0 in Q4 2025, and up 81.07% year-over-year from -$7728.0 in Q1 2025.
BioNexus Gene Lab's Other Working Capital Changes history runs 9 years deep, the most recent figure standing at -$13993.0 for Q1 2026.
- In Q1 2026, Other Working Capital Changes rose 81.07% year-over-year to -$13993.0; the TTM figure through Mar 2026 stood at -$27572.0 (up 77.47% YoY), while the FY2025 annual figure was -$87494.0, down 103.97% from the prior year.
- Other Working Capital Changes came in at -$13993.0 for Q1 2026 at BioNexus Gene Lab, up from -$60683.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $60514.0 in Q2 2025 to a low of -$73915.0 in Q1 2025.
- A 5-year average of -$10275.8 and a median of -$6653.0 in 2023 frame the typical range for Other Working Capital Changes.
- On a YoY basis, Other Working Capital Changes climbed as much as 16756.27% in 2025 and fell as far as 1425.12% in 2025.
- BioNexus Gene Lab's Other Working Capital Changes stood at $14626.0 in 2022, then slumped by 156.19% to -$8218.0 in 2023, then slumped by 125.76% to -$18553.0 in 2024, then tumbled by 227.08% to -$60683.0 in 2025, then jumped by 76.94% to -$13993.0 in 2026.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered -$13993.0, -$60683.0, and -$13410.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Linde | 230.79 Bn | 226.84 Bn | 4.26 Bn |
| 2 | Chemical & Mining Co Of Chile | 127.66 Bn | 124.93 Bn | 778.60 Mn |
| 3 | Sherwin Williams | 72.51 Bn | 72.30 Bn | 2.78 Bn |
| 4 | Ecolab | 70.96 Bn | 70.34 Bn | 1.85 Bn |
| 5 | Air Products & Chemicals | 62.15 Bn | 63.70 Bn | 987.40 Mn |
| 6 | Ppg Industries | 25.04 Bn | 23.57 Bn | 1.66 Bn |
| 7 | LyondellBasell Industries | 21.62 Bn | 21.73 Bn | 701.00 Mn |
| 8 | Albemarle | 20.26 Bn | 19.42 Bn | 500.97 Mn |
| 9 | DuPont de Nemours | 19.45 Bn | 19.56 Bn | 602.00 Mn |
| 10 | BioNexus Gene Lab | 5.34 Mn | 1.38 Mn | -790.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13,993.00 |
| Mar 31, 2026 | -13,993.00 |
| Dec 31, 2025 | -7,700.00 |
| Dec 31, 2025 | -7,700.00 |
| Sep 30, 2025 | -13,410.00 |
| Sep 30, 2025 | -13,410.00 |
| Jun 30, 2025 | 60,514.00 |
| Jun 30, 2025 | 60,514.00 |
| Mar 31, 2025 | -73,915.00 |
| Mar 31, 2025 | -73,915.00 |
| Dec 31, 2024 | -18,553.00 |
| Dec 31, 2024 | -18,553.00 |
| Sep 30, 2024 | -2,076.00 |
| Sep 30, 2024 | -2,076.00 |
| Jun 30, 2024 | -10,225.00 |
| Jun 30, 2024 | -10,225.00 |
| Mar 31, 2024 | -12,041.00 |
| Mar 31, 2024 | -12,041.00 |
| Dec 31, 2023 | -5,369.00 |
| Dec 31, 2023 | -5,369.00 |
| Sep 30, 2023 | 98,018.00 |
| Sep 30, 2023 | 98,018.00 |
| Jun 30, 2023 | -11,663.00 |
| Jun 30, 2023 | -11,663.00 |
| Mar 31, 2023 | -4,366.00 |
| Mar 31, 2023 | -4,366.00 |
| Dec 31, 2022 | -104,876.00 |
| Dec 31, 2022 | -104,876.00 |
| Sep 30, 2022 | -10,628.00 |
| Sep 30, 2022 | -10,628.00 |
| Jun 30, 2022 | 66,094.00 |
| Jun 30, 2022 | 66,094.00 |
| Mar 31, 2022 | -77,276.00 |
| Mar 31, 2022 | -77,276.00 |
| Dec 31, 2021 | -20,169.00 |
| Dec 31, 2021 | -20,169.00 |
| Sep 30, 2021 | 10,921.00 |
| Sep 30, 2021 | 10,921.00 |
| Jun 30, 2021 | -10,921.00 |
| Jun 30, 2021 | -10,921.00 |
| Dec 31, 2020 | 9,031.00 |
| Dec 31, 2020 | 9,031.00 |
| Sep 30, 2020 | -2,163.00 |
| Sep 30, 2020 | -2,163.00 |
| Jun 30, 2020 | -2,924.00 |
| Jun 30, 2020 | -2,924.00 |
| Mar 31, 2020 | -3,944.00 |
| Mar 31, 2020 | -3,944.00 |
| Dec 31, 2019 | 9,758.00 |
| Dec 31, 2019 | 9,758.00 |
| Jun 30, 2019 | 3,970.00 |
| Jun 30, 2019 | 3,970.00 |
| Mar 31, 2019 | -3,970.00 |
| Mar 31, 2019 | -3,970.00 |
| Dec 31, 2018 | -8,170.00 |
| Dec 31, 2018 | -8,170.00 |
| Mar 31, 2018 | 114,144.00 |
| Mar 31, 2018 | 114,144.00 |